Matthew Luchini
BMO Capital Markets
Leah Cann
Brookline Capital Markets
Maneka Mirchandaney / Josh Schimmer, M.D.
Evercore ISI
Andrew Fein
H.C. Wainwright
Kelly Shi
Jefferies
Bradley Canino
Stifel
Christopher Liu
SVB Leerink
Colin Bristow, M.D.
UBS

C4 Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding C4 Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of C4 Therapeutics or its management. C4 Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Toolkit